Survival of patients treated with radiation therapy for anaplastic astrocytoma

Abstract

Background. Anaplastic astrocytoma (AA) represents 7% of primary brain tumors in adults. Patient-, tumor-, and treatment-related factors are thought to be predictive of survival. We retrospectively assessed the association of patient-, tumor-, and treatment-related factors with survival in AA treated with radiotherapy (RT) at our institution.

Keywords

• anaplastic astrocytoma
• radiation therapy
• prognosis
• radiation therapy oncology group recursive partitioning analysis (rtog rpa)
• temozolomide (tmz)
• chemoradiation therapy